ADAM17 and pancreatic ductal adenocarcinoma: In pancreatic ductal adenocarcinoma (PDAC), ADAM17/TACE mRNA expression is upregulated in tumour-derived tissues and cell lines, and siRNA silencing of ADAM17 significantly reduced cancer cell invasion in lab-based models, although proliferation remained unaffected [118].